Zhi Xu
-
- COVID-19 and healthcare impacts 3
- Cancer Immunotherapy and Biomarkers 3
-
- DNA Repair Mechanisms 3
- RNA Interference and Gene Delivery 3
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
-
- COVID-19 Clinical Research Studies 4
-
- Nitric Oxide and Endothelin Effects 2
-
- Antimicrobial Peptides and Activities 2
- Co-authors
- Guansong WangMichael J. HendzelGuy G. PoirierJean‐Philippe GagnéIsmail Hassan IsmailGuisheng QianBinfeng HeHang Qian
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Zhi Xu
34 papers receiving 656 citations
Peers
Comparison fields: 5 of 101
- Oncology 152
- Cancer Research 78
- Pulmonary and Respiratory Medicine 161
- Molecular Biology 321
- Immunology 90
Countries citing papers authored by Zhi Xu
This map shows the geographic impact of Zhi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Xu more than expected).
Fields of papers citing papers by Zhi Xu
This network shows the impact of papers produced by Zhi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Xu. The network helps show where Zhi Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhi Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 25 | |
| 4 | 2021 | 7 | |
| 5 | 2021 | 24 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 3 | |
| 8 | Complications of chronic obstructive pulmonary disease and their effects on prognosis | 2020 | 1 |
| 9 | 2019 | 9 | |
| 10 | 2017 | 30 | |
| 11 | 2017 | 49 | |
| 12 | 2015 | 8 | |
| 13 | 2014 | 151 | |
| 14 | 2014 | 2 | |
| 15 | 2014 | 18 | |
| 16 | 2012 | 16 | |
| 17 | 2010 | 9 | |
| 18 | 2010 | 58 | |
| 19 | 2009 | 6 | |
| 20 | 2009 | 7 |
About Zhi Xu
Zhi Xu is a scholar working on Computational Mathematics, Structural Biology and Infectious Diseases, having authored 34 papers that have together received 663 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), DNA Repair Mechanisms (3 papers), RNA Interference and Gene Delivery (3 papers), COVID-19 and healthcare impacts (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers) and Antimicrobial Peptides and Activities (2 papers). The work is most often cited by research in Oncology (152 citations), Cancer Research (78 citations) and Pulmonary and Respiratory Medicine (161 citations). Zhi Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Guansong Wang, Michael J. Hendzel, Guy G. Poirier, Jean‐Philippe Gagné, Ismail Hassan Ismail, Guisheng Qian, Binfeng He, Hang Qian, Qian Liu and Guangyu Wu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.